|
(b)(6).Based on the available information, this event is deemed to be a reportable malfunction.A batch record review was completed, and no discrepancies were found.All in-process stat sample quality checks were satisfactory.The sample within the batch record was checked for hard matter, but none was identified.Aquacel ag+ extra 15x15cm(1x5pk) ster eur was manufactured under system application product (sap) code 1708334 and manufacturing lot number 3d04407 on 02 may 2023.Lot # 3d04407 was sterilized under reference id 2163-3519a and released on review of results of sterilization provided by sterilization company steris.All of the results were within specification and products were released.No nonconformity was identified during the manufacturing process of lot 3d04407.This is the only complaint for the affected lot registered within database.One photograph was received for this issue so could be evaluated in accordance with work instructions (wi).The photo shows the expected product and complaint issue, where a foreign material can be seen.The lot number of the product is not shown.The foreign matter looks like diffused grey spots.The complaint sample was requested on 25th sept 2023, but it was identified that the complaint sample was not available, as the complainant had sent the dressing to an independent laboratory (surgical manufacturers testing laboratory- smtl).As the dressing under complaint was not available, it was not possible to fully investigate the issue.As the complaint sample was not available, a capa (corrective action / preventive action) and a root cause investigation could not be raised.Without the complaint sample, it is not possible to identify the foreign matter.The grey diffused spots on the dressing look similar to previous examples of foreign matter which was analyzed to conclude excess silver within the dressing.As this is a dressing containing silver, excess silver can discolor and show up as grey diffused spots.The complainant states the foreign matter spots are hard, but without the sample, it is not possible to confirm this aspect of the complaint.A request has been made to the complainant to request a copy of the independent investigation report from the independent party to help us understand the failure mode and address the issue in future.This issue will be monitored through the post market product monitoring review process, standard operating procedure (sop).To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number: reporting site: 1049092.Manufacturing site: 1000317571.
|